Development and Validation of a Practical Two-Step Prediction Model and Clinical Risk Score for Post-Thrombotic Syndrome

被引:37
作者
Amin, Elham E. [1 ,2 ]
van Kuijk, Sander M. J. [2 ]
Joore, Manuela A. [2 ]
Prandoni, Paolo [3 ]
ten Cate, Hugo [1 ,4 ]
ten Cate-Hoek, Arina J. [1 ,4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands
[2] Maastricht Univ, Sch Publ Hlth & Primary Care, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands
[3] Arianna Fdn Anticoagulat, Bologna, Italy
[4] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands
关键词
post-thrombotic syndrome; clinical risk score; prediction model; deep vein thrombosis; validation; DEEP-VEIN THROMBOSIS; CATHETER-DIRECTED THROMBOLYSIS; VENOUS THROMBOSIS; COMPRESSION STOCKINGS; CONTROLLED-TRIAL; PROSPECTIVE COHORT; RANDOMIZED-TRIAL; DETERMINANTS; INFLAMMATION; THERAPY;
D O I
10.1055/s-0038-1655743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Post-thrombotic syndrome (PTS) is a common chronic consequence of deep vein thrombosis that affects the quality of life and is associated with substantial costs. In clinical practice, it is not possible to predict the individual patient risk. We develop and validate a practical two-step prediction tool for PTS in the acute and subacute phase of deep vein thrombosis. Methods Multivariable regression modelling with data from two prospective cohorts in which 479 (derivation) and 1,107 (validation) consecutive patients with objectively confirmed deep vein thrombosis of the leg, from thrombosis outpatient clinic of Maastricht University Medical Centre, the Netherlands (derivation) and Padua University hospital in Italy (validation), were included. PTS was defined as a Villalta score of >= 5 at least 6 months after acute thrombosis. Results Variables in the baseline model in the acute phase were: age, body mass index, sex, varicose veins, history of venous thrombosis, smoking status, provoked thrombosis and thrombus location. For the secondary model, the additional variable was residual vein obstruction. Optimism-corrected area under the receiver operating characteristic curves (AUCs) were 0.71 for the baseline model and 0.60 for the secondary model. Calibration plots showed well-calibrated predictions. External validation of the derived clinical risk scores was successful: AUC, 0.66 (95% confidence interval [CI], 0.63-0.70) and 0.64 (95% CI, 0.60-0.69). Conclusion Individual risk for PTS in the acute phase of deep vein thrombosis can be predicted based on readily accessible baseline clinical and demographic characteristics. The individual risk in the sub-acute phase can be predicted with limited additional clinical characteristics.
引用
收藏
页码:1242 / 1249
页数:8
相关论文
共 34 条
[1]  
Ageno W, 2003, THROMB HAEMOSTASIS, V89, P305
[2]  
Appelen D, 2017, COCHRANE DB SYST REV, V9
[3]   Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome [J].
Bouman, A. C. ;
Smits, J. J. M. ;
Ten Cate, H. ;
Ten Cate-Hoek, A. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) :1532-1538
[4]   Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis [J].
Brandjes, DPM ;
Buller, HR ;
Heijboer, H ;
Huisman, MV ;
deRijk, M ;
Jagt, H ;
tenCate, JW .
LANCET, 1997, 349 (9054) :759-762
[5]   Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study [J].
Chitsike, R. S. ;
Rodger, M. A. ;
Kovacs, M. J. ;
Betancourt, M. T. ;
Wells, P. S. ;
Anderson, D. R. ;
Chagnon, I. ;
Le Gal, G. ;
Solymoss, S. ;
Crowther, M. A. ;
Perrier, A. ;
White, R. H. ;
Vickars, L. M. ;
Ramsay, T. ;
Kahn, S. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) :2039-2044
[6]  
Collins GS, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.g7594, 10.1111/1471-0528.13244]
[7]   Prevention and treatment of postphlebitic syndrome - Results of a 3-part study [J].
Ginsberg, JS ;
Hirsh, J ;
Julian, J ;
Vander LaandeVries, M ;
Magier, D ;
MacKinnon, B ;
Gent, M .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (17) :2105-2109
[8]   Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation [J].
Guanella, R. ;
Ducruet, T. ;
Johri, M. ;
Miron, M. -J. ;
Roussin, A. ;
Desmarais, S. ;
Joyal, F. ;
Kassis, J. ;
Solymoss, S. ;
Ginsberg, J. S. ;
Lamping, D. L. ;
Shrier, I. ;
Kahn, S. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) :2397-2405
[9]   Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial [J].
Haig, Ylva ;
Enden, Tone ;
Grotta, Ole ;
Klow, Nils-Einar ;
Slagsvold, Carl-Erik ;
Ghanima, Waleed ;
Sandvik, Leiv ;
Hafsahl, Geir ;
Holme, Pal Andre ;
Holmen, Lars Olaf ;
Njaaastad, Anne Mette ;
Sandbaek, Gunnar ;
Sandset, Per Morten .
LANCET HAEMATOLOGY, 2016, 3 (02) :E64-E71
[10]  
Ippolito E, 2011, Panminerva Med, V53, P13